Health24.com | Speed up stroke recovery with exercise

Aerobic exercise significantly improves stroke survivors’ endurance and walking ability, researchers report.

They analysed 19 studies that included nearly 500 stroke survivors, aged 54 to 71, who completed aerobic exercise programmes similar in structure to cardiac rehabilitation.

Significant improvements

The patients did two or three aerobics workouts a week for about three months. Walking was the most common type of activity, followed by stationary cycling and mixed aerobic exercise. The patients’ endurance and walking speed were tested before and after they completed the programmes.

Overall, the patients had significant improvements. After completing the therapy, they walked an average of nearly half the length of a football field farther during a six-minute walking test. Those with mild movement impairments had the best results.

“These benefits were realised regardless of how long it had been since their stroke,” said study lead author Elizabeth Regan, a Ph.D. candidate in exercise science at the University of South Carolina.

Mixed aerobic exercise provided the greatest improvement, followed by walking, cycling and recumbent stepping – a machine that allows stepping while in a seated position.

The study was published in the Journal of the American Heart Association.

Leading cause of disability

“Our analysis included stroke survivors across a wide range, from less than six months to greater than a year since their stroke, and the benefits were seen whether they started an aerobic exercise programme one month or one year after having a stroke,” Regan explained in a journal news release.

Stroke is the leading cause of disability in the United States. Physical therapy is often prescribed for stroke survivors to improve physical impairments. Most current stroke rehabilitation has little to no focus on aerobic fitness.

“The physical therapy we currently provide to patients after a stroke focuses more on improving the ability to move and move well rather than on increasing how far and long you can move,” Regan said. “It doesn’t matter how well you can walk if your endurance level keeps you at home.”

Study co-author Stacy Fritz, an associate professor of exercise science at the University of South Carolina, said that cardiac rehabilitation programmes may offer benefits to stroke patients “who have health risks and endurance losses similar to traditional cardiac rehab participants.

“Almost every hospital has a cardiac rehab programme, so it’s an existing platform that could be used for stroke survivors. Funnelling patients with stroke into these existing programmes may be an easy, cost-effective solution with long-term benefits,” Fritz said.

Image credit: iStock

Share Button

Gene therapy for rare eye disease set to be offered on NHS

Patients with a rare inherited eye disorder are set to be offered a new gene therapy on the NHS.

Share Button

Take your sandals to the gym, pool

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Share Button

Cannabis may hold promise to treat PTSD but evidence lags behind use

As growing numbers of people are using cannabis to treat post-traumatic stress disorder (PTSD), a new UCL study reports that prescriptions are not backed up by adequate evidence.

The systematic review, published in the Journal of Dual Diagnosis, finds that the active components of cannabis, called cannabinoids, may hold promise as a treatment for PTSD, particularly for reducing nightmares and helping people sleep, but more research is needed to determine whether these drugs should be used in routine clinical practice.

“There has been a recent surge of interest in the use of cannabinoids to treat PTSD, particularly from military veterans, many of whom are already self-medicating or obtaining prescriptions in some American states,” said the study’s lead author, Dr Chandni Hindocha (UCL Clinical Psychopharmacology Unit).

“The lack of evidence supporting cannabis as a PTSD treatment is striking given the vast interest in it, and the large unmet need for better PTSD treatments,” she said.

PTSD is a potentially debilitating condition affecting roughly 1% of the UK population, typically consisting of re-experiencing a traumatic event through intrusive memories, flashbacks or nightmares, and often involves hyper-reactivity (a state of constant vigilance) and insomnia.

Psychotherapies (talking therapies) including trauma-focussed cognitive-behavioural therapy have been shown to be effective for PTSD. However, not everyone can access talking therapies and they do not work for everyone, so many people still need to take prescribed medications. Existing drugs approved for PTSD do not work for everyone, and can have side effects, so researchers say there is an urgent need to identify new treatments.

A growing number of people have turned to cannabinoids, which is an approved treatment for PTSD in most states in the USA that permit medical cannabis.

Cannabinoids, the active ingredients of cannabis, which include tetrahydrocannabinol (THC) and cannabidiol (CBD), may be helpful at treating PTSD as they can change how the brain processes memories. The cannabinoids act on the brain’s in-built endocannabinoid system which also regulates other brain functions that are affected by PTSD.

The research team conducted a systematic review of all studies where someone with a PTSD diagnosis has been using a cannabinoid to reduce their symptoms, and they assessed the quality of each study.

They found 10 studies that met their criteria, which cover a range of products including smoked cannabis, THC or CBD separately in oil or pill form, and a synthetic cannabinoid called nabilone.

Every study had medium to high risk of bias and all were assessed as low in quality due to limitations such as small sample size, retrospective study design, lack of a control group or placebo, short follow-up periods, and not reporting other medication use or addiction. Only one study was a randomised controlled trial, investigating nabilone, but it was in a small sample over a relatively short period of time.

The researchers say there are still many unanswered questions about the safety and efficacy of cannabis-based medications for PTSD, and potential long-term effects such as addiction or a risk of psychosis.

The existing evidence shows promise, however, as some studies showed that cannabis products appeared to reduce PTSD symptoms such as insomnia and nightmares.

“Based on the evidence, we cannot yet make any clinical recommendations about using cannabinoids to treat PTSD. Current prescribing of cannabinoids for PTSD is not backed up by high quality evidence, but the findings certainly highlight the need for more research, particularly long-term clinical trials,” said the study’s senior author, Dr Michael Bloomfield (UCL Psychiatry and the Traumatic Stress Clinic, St Pancras Hospital).

“Many of these studies have been conducted in military veterans, but we also need to be looking at other groups, as PTSD can vary depending on the nature of the trauma so different approaches may benefit different groups,” he added.

Dr Hindocha added: “Unfortunately, medicinal uses of cannabis have historically been difficult to study due to legal restrictions, so it could take a long time before there is enough evidence to support clinical recommendations. New approaches are needed to make the most of existing evidence in the meantime.”

The study was conducted by researchers at UCL and the University of Amsterdam, and was supported by the National Institute for Health Research UCLH Biomedical Research Centre.

Share Button

New light shed on demise of two extinct New Zealand songbirds

They may not have been seen for the past 50 and 110 years, but an international study into their extinction has provided answers to how the world lost New Zealand’s South Island kokako and huia.

Lead author Dr Nicolas Dussex, of the University of Otago, New Zealand, and Swedish Museum of Natural History, says the team set out to investigate if it was external (habitat loss, mammalian predators) or internal (demography, genetic effects) factors which led to their extinction.

Very little was known about the forest songbirds he describes as “iconic and somehow mysterious,” which were last seen in 1960s and 1907 respectively, but recent advances in the extraction and analysis of ancient DNA provided the opportunity scientists needed to find out more.

The study, just published in Biology Letters, produced what Dr Dussex calls “very surprising” results.

The researchers mapped the birds’ complete genomes and saw a response to ice age climate change many thousands of years ago, but no signs of genetic problems common in small populations such as inbreeding. This suggests a rapid population decline possibly caused by habitat loss and new predators introduced by the Europeans.

“Because even the earliest Polynesian settlers more than 700 years ago had a significant impact on forest cover, we would have expected huia and South Island kokako populations to have survived at small population sizes for centuries and thus to have experienced an increase in inbreeding.

“However, our data did not show evidence for inbreeding and indicated that the two species still had quite a bit of genetic diversity close to the time of extinction. This means that their extinction was most likely not driven by genetic effects and inbreeding, but that further habitat loss and introduction of mammalian predators by European must have triggered a rapid extinction,” he says.

Dr Dussex says this is the first study to generate high-quality genomes from historical specimens of extinct New Zealand species.

“Using complete genomes allowed us to reconstruct the birds’ population history, and, more importantly, to determine whether genetic effects could have contributed to their extinction.

“While we focused here on two extinct species, understanding the role of genetic effects in the extinction process is extremely relevant to the study of declining and inbred populations, such as the kakapo, saddleback, and kiwi. This knowledge can thus contribute the conservation and recovery of endangered species potentially exposed to negative genetic effects.”

Co-author Dr Michael Knapp, of Otago’s Department of Anatomy, says the team hopes its work will stimulate similar research in other extinct or endangered endemic species from New Zealand.

“Recent advances in ancient DNA mean that it is the right time to study extinction from a genomics perspective. So far, very little is known about the role genetic effects play in the process of extinction. This research is thus very timely and extremely relevant to the understanding of the decline in biodiversity in New Zealand.”

Story Source:

Materials provided by University of Otago. Note: Content may be edited for style and length.

Share Button

Finding an effective way to reduce pressure ulcers

Expensive high-tech air mattresses are only marginally better at preventing pressure sores and ulcers than a specialist foam mattress, according to the results of a major study.

Known as an alternating-pressure mattress, the high-tech devices contain air pockets that inflate and deflate to constantly change pressure points on the skin. They cost at least £1,000 each (US $1,217).

In comparison, a specialist foam mattress is around £200 (US $243) and is made up of high-quality polyurethane and viscoelastic foam designed to cradle the patient to reduce pressure on the skin.

The specialist foam mattresses are in widespread use across the NHS (National Health Service). The high-tech air mattresses are found on approximately 10% of NHS hospital beds and given to patients considered to be at high risk of pressure ulcers even though there has been no independent evaluation of their effectiveness.

The UK Government’s health regulator, the National Institute of Health and Care Excellence, had called for a scientific trial to investigate the benefits of the high-tech mattresses.

That study, led by nurse researchers at the University of Leeds, is published today (04/09/19) in the journal EClinicalMedicine.

Clinical benefit

The investigation showed that the gains from the use of the high-tech air mattresses were marginal. The paper concludes that for every 50 patients allocated to one of the high-tech air mattresses, only one would benefit from it.

The results showed that 6.9% of patients on the high-tech air mattresses developed a pressure sore that was grade two (ie blister or break in the skin) or worse compared with 8.9% on the specialist foam mattress. Ulcers are graded on a scale from one to four, with four being the most serious.

The median length of time it took for the ulcers to develop for the patients on a high-tech air mattress was 18 days compared to 12 days for those on the specialist foam mattress.

The paper — Pressure relieving support surfaces for pressure ulcer prevention: clinical and health economic results of a randomised controlled trial — also noted that the overall number of patients who developed pressure sores during the study was smaller than expected: the result, the researchers believe, of changes in nursing practice designed to reduce the burden of pressure sores.

This is the first large-scale study world-wide into the effectiveness of high-tech air and specialised foam mattresses to prevent pressure sores. It involved more than 2000 patients at high risk of developing pressure sores in hospital and NHS community units.

In 2018, NHS Improvement described pressure sores as a “concerning and avoidable harm” with the costs to the NHS of treating the condition running at more than £3.8 million every day.

Pressure sores are a major complication faced by people who are bedridden or immobile. The pressure that builds on soft tissue causes distortion to the tissues and/or an interruption to the blood supply — and that kills or damages skin leading to painful ulcers.

The study was led by Jane Nixon, Professor of Tissue Viability and Clinical Trials at the University of Leeds.

She said: “The professional guidelines tell healthcare staff that they should use specialist foam for all at-risk patients and high-tech air- mattresses for patients with an existing pressure ulcer when adequate pressure distribution cannot be achieved.

“But in practice, some nurses provide high-risk patients as well as those with existing pressure ulcers with the high-tech air mattresses and there has not been any evaluation of the effectiveness of one type of mattress over another.

“Some patients find the air mattress unsettling. They are kept awake by the noise of the pump, feel unsafe because the mattress is moving, or just find them uncomfortable.

“Rehabilitating patients also complain that they can’t move around themselves or get in and out of bed — and that exacerbates already limited mobility.”

Patients who agreed to take part were randomly allocated to either a high-tech air or specialised foam mattress for 2 months or until discharge, whichever came sooner. They were then assessed by a nurse for a final time 30 days after discharge. The majority of the patients were elderly, with the median age 81 and included a number of patients who were aged over 100.

The analysis suggested that the patients who benefitted most from the high-tech air mattresses were those who were completely immobile, confused, had nutritional deficits and very red skin on a pressure area.

Financial evaluation

The study found an economic advantage to using the high-tech air pressure mattresses. Although they cost more to buy, the patients who were nursed on them had, on average, a slightly shorter stay in hospital, and that reduced the overall cost of care.

More research is needed to fully understand the correlation between mattress type and length of hospital stay.

While acknowledging that there were benefits to using the high-tech air pressure mattresses, the researchers said that as the gains were small, the advice to nurses should be that most patients could be safely cared for on a specialised foam mattress.

Professor Nixon said: “The outcome of this study provides the evidence that specialist foam mattresses are appropriate for most patients who are at high risk of developing pressure ulcers.

“But staff should be free to exercise clinical discretion in provision of either mattress, informed by patient preference, comfort or rehabilitation needs as well as specific risk factors such as being completely immobile, being confused, having nutritional deficits or early signs of pressure damage.”

Share Button

Suicide rate rises for first time since 2013

The suicide rate in the UK has risen for the first time in five years, official figures show.

Share Button

Cancer ‘biggest middle-age killer in rich nations’

Cancer claims more lives than cardiovascular disease in wealthy countries but the reverse is true for poorer nations.

Share Button

Health24.com | WATCH: This is how avocados could help you lose weight

03 September 2019

WATCH: This is how avocados could help you lose weight

Known for their wide range of health benefits, avocados can assist with weight loss.

Avocados provide a wide range of health benefits. They contain good fats, also known as monounsaturated fats, which are a good way to keep you fuller for longer. In addition to this, they can help protect against heart disease and help with weight loss. 

NEXT ON HEALTH24X

Live healthier

Share Button

Health24.com | Investigations underway after expired medicine was found at a Clicks pharmacy

The Limpopo branch of the South African Human Rights Commission (SAHRC) has launched an investigation after customers complained they had been sold expired medication at a Clicks Pharmacy. 

The Commission’s provincial manager Victor Mavhidula paid a surprise visit to the store in Thavhani Mall in Thohoyandou last week where he found flu medicine that had passed its sell-by date.

“We visited the pharmacy after we received complaints from customers who were allegedly sold expired medication and, on arrival, we found expired medication inside the store.

“It’s our duty to protect the health and lives of our people which is why weacted swiftly,” said Mavhidula.

He said the Commission would engage the pharmacy further saying it was unacceptable to sell people expired medication that could have a negative impact on their health.

“We call on our people to always check the expiry dates of every medication they buy at [all] pharmacies before they use them. We will be taking the matter further as it is our duty to protect our people,” he said.

The expiration date on medications can be found printed on the label or stamped on to the bottle.

Expired meds could be unsafe

Pharmacist Ndandu Netshiavha has warned people against using expired drugs because this could be unsafe.

“An expiry date on medicine is a date up to which a medicine manufacture can guarantee the safety and efficacy of the medicine. 

“This is a legal requirement imposed by the South African Health Products Regulatory Authority as the safety and efficiency of medicines after the expiry date cannot be guaranteed and some medicines if taken after they have expired can make you sick,” she explained. 

Expired medicine should never be thrown in the dust bin or flushed down the drain or toilet because it could contaminate water, Netshiavha added.

He urged people to take expired medicines to their nearest pharmacy which are equipped with the means for disposal.

Own investigation

When Health-e visited the Clicks Pharmacy in Thohoyandou, the store manager declined to speak, saying the matter had been referred to its provincial head office.

Speaking to Health-e, Clicks spokesperson Susann Caminada said the chain store has begun its own investigation.

She said: “We take complaints of this nature very seriously. We’re currently investigating the matter and are therefore unable to provide a full comment at this stage.

“We comply with South African Pharmacy Council regulations and have various processes and procedures in place within our pharmacies, including a triple check process to ensure that expired medication is not dispensed to the public.”

– Health-e News

Image credit: iStock

Share Button